Genelux Corp has a consensus price target of $30.5 based on the ratings of 4 analysts. The high is $40 issued by Maxim Group on September 12, 2023. The low is $25 issued by Benchmark on June 3, 2024. The 3 most-recent analyst ratings were released by Benchmark, Benchmark, and HC Wainwright & Co. on June 3, 2024, May 31, 2024, and May 13, 2024, respectively. With an average price target of $27.33 between Benchmark, Benchmark, and HC Wainwright & Co., there's an implied 1171.32% upside for Genelux Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/03/2024 | Buy Now | 1062.79% | Benchmark | Bruce Jackson | $25 → $25 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
05/31/2024 | Buy Now | 1062.79% | Benchmark | Bruce Jackson | $30 → $25 | Maintains | Speculative Buy | Get Alert |
05/13/2024 | Buy Now | 1388.37% | HC Wainwright & Co. | Emily Bodnar | → $32 | Reiterates | Buy → Buy | Get Alert |
04/03/2024 | Buy Now | 1295.35% | Benchmark | Bruce Jackson | → $30 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
04/02/2024 | Buy Now | 1388.37% | HC Wainwright & Co. | Emily Bodnar | $35 → $32 | Maintains | Buy | Get Alert |
11/27/2023 | Buy Now | 1527.91% | HC Wainwright & Co. | Emily Bodnar | → $35 | Initiates | → Buy | Get Alert |
11/24/2023 | Buy Now | 1295.35% | Benchmark | Bruce Jackson | $38 → $30 | Maintains | Speculative Buy | Get Alert |
09/12/2023 | Buy Now | 1760.47% | Maxim Group | Jason McCarthy | → $40 | Initiates | → Buy | Get Alert |
06/09/2023 | Buy Now | 1667.44% | Benchmark | Bruce Jackson | $10 → $38 | Maintains | Speculative Buy | Get Alert |
05/18/2023 | Buy Now | 1062.79% | Brookline Capital | Kemp Dolliver | → $25 | Initiates | → Hold | Get Alert |
02/15/2023 | Buy Now | 365.12% | Benchmark | Bruce Jackson | → $10 | Initiates | → Speculative Buy | Get Alert |
The latest price target for Genelux (NASDAQ:GNLX) was reported by Benchmark on June 3, 2024. The analyst firm set a price target for $25.00 expecting GNLX to rise to within 12 months (a possible 1062.79% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for Genelux (NASDAQ:GNLX) was provided by Benchmark, and Genelux reiterated their speculative buy rating.
There is no last upgrade for Genelux
There is no last downgrade for Genelux.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Genelux, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Genelux was filed on June 3, 2024 so you should expect the next rating to be made available sometime around June 3, 2025.
While ratings are subjective and will change, the latest Genelux (GNLX) rating was a reiterated with a price target of $25.00 to $25.00. The current price Genelux (GNLX) is trading at is $2.15, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.